RE: Patience9 Oct 2020 11:41
@ Magsy,
Why do you post such negativity about GDR, when you have such a Large investment in GDR ?
You know the reason that DB cannot firm up Sells is because we need our targeted Market Approvals, and this is taking a lot longer than 'ANY ONE' could ever have imagined ?These Approvals are out of DB's control.
You also know that we are targeting the 'Massive Markets' in Africa; India and USA !
We have received an Approval from South Africa, 'just last week', and it will take time for Contracts to pass through from here, but I am sure it will happen !
We have GHIF supporting us in Africa and India etc, and I am certain this will benefit us 'BIG TIME' both in financial support into these Countries, and in their Massive Experience in these Market area's !
Once the Approvals 'Country wide' in Africa come through, and in India, and in USA, Big and I mean Big sells will come through !
Until these APPROVALS COME THROUGH - WE CANNOT SELL IN THESE COUNTRIES - QUITE SIMPLE REALLY - BUT YOU KNOW THIS ?
It is because DB targeted these Markets, 'from the outset', that I believe GDR will over take NCYT sells, and will prove to be the Best stock to BUY in this Market, today !
I know you can smile when our Shares start to show some of the promise, that most of us are expecting, but you turn massively negative, as soon as our SP drops back, from any nice run ?
Keep your 'Chin Up Chap', and focus on the Positivity of GDR's future !
'YOU KNOW THIS MAKES SENCE'
Extracts from some of my previous Posts:
Africa; India and USA are our Targeted Markets, and this is why DB has cleverly chosen these markets:
Population of Africa 2020 = 1,348,301,517
Population of India 2020 = 1,380,004,385
Population of USA 2020 = 331,000,000
Massive new cases and deaths in Africa; India and USA, and these Countries will need GDR/BC Tests !
COVID Tests will be with us for many years to come, way past COVID Vaccine World wide availability, IMHO.
Extract from my post on 12th Sept: - GDR Potential: -
I believe that GDR Mcap is potentially worth £300 mil Mcap, based on projected Sales and Profit.
I expect GDR to sell 50,000 RT-PCR Test units/day at £10 per Test = £500,000 per day revenue at 60% profit margin = £300,000 per day profit.
Working on a 5 day week = 5 x £300,000 = £1,500,000 profit per week.
£1,500,000 x 50 wks per year = £75,000,000 profit per year.
Using a standard multiple of 4 for valuation = 4 x £75,000,000 = Mcap of £300,000,000
Mcap of £300,000,000 divided by 52,000,000 shares = a potential SP of £5.77p
This Mcap valuation did not take into consideration a valuation of our POC; HCV OR AIHL etc
Sign In
Follow the stocks
